Modul 2
Individual dose adjustment of riociguat in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension - ScienceDirect
First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension | European Respiratory Society
Riociguat dose-adjustment scheme. SBP systolic blood pressure, TID... | Download Scientific Diagram
Riociguat: Clinical research and evolving role in therapy - Klinger - 2021 - British Journal of Clinical Pharmacology - Wiley Online Library
Individual dose adjustment of riociguat in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension - ScienceDirect
Riociguat: Mode of Action and Clinical Development in Pulmonary Hypertension | Semantic Scholar
Case report: a patient with pulmonary arterial hypertension transitioning from a PDE-5 inhibitor to Riociguat – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on
Practical Considerations With New Therapies in CTEPH and PAH: Dosing, Titrating, and Switching (Transcript)
Riociguat
Adempas for Patients - MedEd Center
Riociguat | CAS 625115-55-1 | Cayman Chemical | Biomol.de
Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry - ScienceDirect
Riociguat (Adempas) - Uses, Dose, MOA, Brands, Side effects
Adempas® 2,5 mg 294 St - shop-apotheke.com
Adempas® 2,5 mg 294 St - shop-apotheke.com
JCM | Free Full-Text | Riociguat in Patients with CTEPH and Advanced Age and/or Comorbidities
Riociguat for the Treatment of Raynaud's Phenomenon: A Single-Dose, Double-Blind, Randomized, Placebo-Controlled Cross-Over Pilot Study (DIGIT) | springermedizin.de
Riociguat | PHA
Individual dose adjustment of riociguat in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension - ScienceDirect
Clinical Pharmacokinetic and Pharmacodynamic Profile of Riociguat | SpringerLink
Riociguat (BAY 63-2521) and Aspirin: A Randomized, Pharmacodynamic, and Pharmacokinetic Interaction Study - Reiner Frey, Michael Reber, Jörn Krätzschmar, Sigrun Unger, Wolfgang Mück, Georg Wensing, 2016
Riociguat – Chemie-Schule
JCM | Free Full-Text | Riociguat in Patients with CTEPH and Advanced Age and/or Comorbidities
Population Pharmacokinetics of Single-Dose Riociguat in Patients with Renal or Hepatic Impairment - Soundos Saleh, Corina Becker, Reiner Frey, Wolfgang Mück, 2016
ADEMPAS Dosage & Rx Info | Uses, Side Effects
